The FDA approved the first topical ruxolitinib cream in September 2021 for treating atopic dermatitis in patients 12 years and older, basing its decision on results from the TRuE-AD1 (NCT03745638 ...

Unlike lichen sclerosus, for which the risk of cutaneous malignancy in untreated cases is well established, [] the risk of neoplastic change in erosive genital lichen planus is less certain ...

Topical tacrolimus is similarly effective for genital lichen planus. A retrospective review of 16 patients with vulvar lichen planus who used 0.1% topical tacrolimus twice daily showed that 15 ...

It is the first US approval for a topical gene therapy, according to the regulator, which has said Vyjuvek (beremagene geperpavec) can be used to treat patients aged six months of over who have ...